AMDINOCILLIN: 23 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
23
Total FAERS Reports
0
Deaths Reported
17
Hospitalizations
23
As Primary/Secondary Suspect
4
Life-Threatening
1
Disabilities
Dec 21, 1984
FDA Approved
Discontinued
Status
FDA Application: 050565 ·
First Report: 20150506 · Latest Report: 20220901
What Are the Most Common AMDINOCILLIN Side Effects?
#1 Most Reported
Tricuspid valve incompetence
8 reports (34.8%)
#2 Most Reported
Right ventricular failure
8 reports (34.8%)
#3 Most Reported
Congenital pulmonary hypertension
8 reports (34.8%)
All AMDINOCILLIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Congenital pulmonary hypertension | 8 | 34.8% | 0 | 5 |
| Right ventricular failure | 8 | 34.8% | 0 | 5 |
| Tricuspid valve incompetence | 8 | 34.8% | 0 | 5 |
| Ascites | 7 | 30.4% | 0 | 4 |
| Ductus arteriosus premature closure | 7 | 30.4% | 0 | 4 |
| Foetal exposure during pregnancy | 7 | 30.4% | 0 | 5 |
| Foetal heart rate abnormal | 7 | 30.4% | 0 | 4 |
| Generalised oedema | 7 | 30.4% | 0 | 4 |
| Cyanosis | 6 | 26.1% | 0 | 3 |
| Tubulointerstitial nephritis | 5 | 21.7% | 0 | 5 |
Who Reports AMDINOCILLIN Side Effects? Age & Gender Data
Gender: 95.2% female, 4.8% male. Average age: 70.9 years. Most reports from: FR. View detailed demographics →
Is AMDINOCILLIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 0 |
| 2018 | 2 | 0 | 2 |
| 2019 | 3 | 0 | 3 |
| 2020 | 1 | 0 | 1 |
| 2022 | 5 | 0 | 5 |
What Is AMDINOCILLIN Used For?
| Indication | Reports |
|---|---|
| Urinary tract infection | 9 |
Official FDA Label for AMDINOCILLIN
Official prescribing information from the FDA-approved drug label.